期刊文献+

神经降压素的固相合成工艺研究 被引量:3

Technology of Solid-Phase Synthesis of Neurotensin
下载PDF
导出
摘要 神经降压素是由13个氨基酸残基组成的生物活性多肽,具有多重生理功能,且高活性、作用快速,可作为潜在的安定药、镇痛药和降压药等,具有广阔的应用前景。本研究主要进行了神经降压素固相合成的工艺研究。以Fmoc保护的氨基酸为原料,Wang树脂为载体,按照神经降压素的氨基酸序列,从C端向N端进行合成。考察了缩合试剂、脱保护试剂、脱出树脂等条件对合成效果的影响,确定了合成工艺:以二氯甲烷(DCM)为反应溶剂,O-苯并三氮唑-N,N,N′,N′-四甲基脲四氟硼酸酯(TBTU)/1-羟基苯并三氮唑(HOBT)/N,N-二异丙基乙胺(DIEA)为缩合体系,采用(三氟乙酸(TFA)/H2O/甲基苯基硫醚(thioanisole)/Phenol/乙二硫醇(EDT)体系,体积比为82∶5∶5∶6∶2的下树脂条件,2倍过量保护氨基酸进行缩合反应,反应时间为3h。反应结果使神经降压素粗品的收率达61.8%,纯度达46%。 Neurotensin(NT) is a kind of bioactive peptide which is composed of 13 amino acids. It has multifunctions, especially in pain relieving and blood hypertension. Thus it has broad applications as potential nerve medicines in the field of medicial area. NT was synthesized successfully from C-terminal to N-terminal according to the amino acids sequence with the raw material of Fmoc-amino acids and Wang resin as the vector. The influences of combination, deblock and cleavage reagents on the final result of synthesis were discussed. The optimized technology of NT synthesis was as follows: using DCM as the coupling solvent, TBTU/HOBT/DIEA as the coupling reagent, resin with TFA/H2O/thioanisole/Phenol/EDT (Volune ratio of 82: 5:5:6:2) as the cleavage condition, the reaction time 3 h. The yield of crude product was 61.8%, the purity of the product was 46 %.
出处 《化学工业与工程》 CAS 2009年第4期292-297,共6页 Chemical Industry and Engineering
基金 教育部留学回国人员科研启动基金 天津市高等学校科技发展基金项目(重点ZD200716)
关键词 神经降压素 固相合成 工艺研究 neurotensin solid-phase synthesis technology
  • 相关文献

参考文献12

  • 1CARYAWAY R E,LEEMAN S E.The isolation of a new hypotensive peptide,neurotensin from bovine hypothalamus[J].Biol Chem,1973,248(19):6 854-6 861.
  • 2陈家津,吕秀文,徐珞.功能性头痛病人脑脊液神经降压素含量的改变[J].中国应用生理学杂志,1992,8(1):74-75. 被引量:5
  • 3GULLO L,PEZZILLI R.TOMASSETTI P,et al.Plasma cholecystokinin and neurotensin after an ordinary meal in humans:A prolonged time study[J].Castmenteml Clin Bjol,1998,22(1):25-28.
  • 4COLLIER N A,WEINBREN K,BLOOM S R,et al.Neurotensin secretion by fibrolmeler caroinoma of the live[J].The Lancet,1984(1):538-540.
  • 5ZADINA J E,HACKLER L,GE L J,et al.A potent and selective endogenous agonist for the mu-opiate receptor[J].Nature,1997,386:499-501.
  • 6MAEHIDA R,TOKUMURA T,TSUEHIYA Y,et al.Pharmacokineties of novel hexapeptides with neurotensin activity in rats[J].Biol Pharm Bull,1993,16(1):43-47.
  • 7景文鹏,吴蕾.Fmoc固相合成神经降压素[J].中国现代医生,2008,46(16):39-40. 被引量:2
  • 8KALSER E,COLESCOTT L,BOSSING C D,et al.Color test for detection of terminal amino groups in the solid phase synthesis of peptdes[J].Anal Biochem,1970,34:595.
  • 9邹永水 钱肖贞.固相上氨基酸与多肽氨基的测定[J].生物化学与生物物理进展,1978,(4):12-12.
  • 10韩香.Fmoc方法固相合成胸腺素a1[D].天津:天津大学,2000.

二级参考文献5

  • 1邹永水 钱肖贞.固相上氨基酸与多肽氨基的测定[J].生物化学与生物物理进展,1978,(4):12-12.
  • 2[1]Caryaway RE,Leeman SE.The isolation of a new hypotensive peptide,neurotensin from bovine hypothalami[J].J Biol Chem,1973,248(19):6854-6861.
  • 3谢俊霞,陈家津.侧脑室注射抗神经降压素血清对大鼠痛阈的影响[J]青岛医学院学报,1987(02).
  • 4陈家津,崔瑞耀,祝元祥,宋朝佑.神经降压素的放射免疫测定[J]青岛医学院学报,1985(01).
  • 5黄鹤,万里鹏,吴蕾,甘一如.液相色谱法分离纯化固相合成的胸腺素α1[J].化学工业与工程,2001,18(6):331-335. 被引量:7

共引文献14

同被引文献24

  • 1林浩,王德心.哌嗪二酮衍生物的合成研究进展[J].药学学报,2003,38(5):395-400. 被引量:11
  • 2MAS-MORUNO C,RECHENMACHER F,KESSLER H. Cilengitide :The first anti-angiogenic small molecule drug candidate. Design, synthesis and clinical evaluation [ J ]. Anti-Cancer Agents in Medicinal Chemistry, 2010, 10: 753 -768.
  • 3HEHLGANS S, MICHAEL H,NILS C. Signalling via integrins: Implications for cell survival and anticancer strategies [J]. Biochimica et Biophysica Acta, 2007, ( 1775 ) : 163 - 180.
  • 4KALSER E,COLESCOTT R L, BOSSING C D, et al. Color test for detection of terminal amino groups in the solid phase synthesis of peptides [ J ]. Anal Biochem,1970,34:595 -598.
  • 5SEWALD N,JAKUBKE H J. Peptides-Chemistry and biology[ M ]. Germany : Wiley-VCH ,2002.
  • 6CUPIDO T, SPENGLER J, RUIZ-RODRIGUEZ J, et al. Amide-to-ester substitution allows fine-tuning of the cy- clopeptide conformational ensemble [ J ]. Angew Chem Int Ed Engl,2010,49( 15 ) :2 732 -2 737.
  • 7CLARK R J,AKCAN M, KAAS Q,et al. Cyclization of conotoxins to improve their biopharmaceutical properties [ J/OL ]. Toxicon ( 2010 ) , doi: 10. 1016/j. toxicon. 2010 - 12 -03.
  • 8DAI X,SU Z, LIU J. An improved synthesis of a selective oG/33-integrin antagonist cyclo (-RGDfK-) [ J]. Tetrahedron Letters ,2000 (41) :6 295 -6 298.
  • 9George G. Holz and Oleg G. Chepurny. Glucagon-Like Peptide-1 Synthetic Analogs:New Therapeutic Agents for Use in the Treat- ment of Diabetes Mellitus[J]. Curr Med Chem, 2003, 10 (22) :2471.
  • 10Norbert Sewald, Hans-Dieter. Jakubke Peptides-Chemistry AndBiology [ M ]. Weinheim, Wiley-VCH ,2002.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部